R. Thompson

发表

Inherited disorders of transport in the liver.

Richard J. Thompson, S. Strautnieks, R. Thompson, 2000, Current opinion in genetics & development.

Genetic defects in hepatocanalicular transport.

P. Jansen, R. Thompson, 2000, Seminars in liver disease.

Pediatric liver disease.

R. Thompson, Richard Thompson, 1999, Current opinion in gastroenterology.

BSEP: Function and Role in Progressive Familial Intrahepatic Cholestasis

S. Strautnieks, R. Thompson, Richard Thompson, 2001, Seminars in liver disease.

EP1231: ODEVIXIBAT THERAPY IMPROVES CLINICALLY MEANINGFUL ENDPOINTS IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS

L. D’Antiga, H. Verkade, S. Karpen, 2022, Gastroenterology.

Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome

R. Sokol, B. Kamath, Robert H. Squires, 2022, Hepatology communications.

EP1233: LONG-TERM TREATMENT WITH ODEVIXIBAT IMPROVES MULTIPLE SLEEP PARAMETERS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: A POOLED RESPONDER ANALYSIS FROM THE PHASE 3 PEDFIC STUDIES

P. Horn, P. Calvo, C. Mack, 2022, Gastroenterology.

PMU62 Improved Quality of Life in Children With Progressive Familial Intrahepatic Cholestasis Following 24 Weeks of Treatment With Odevixibat, an Ileal Bile Acid Transporter Inhibitor: Results From the Phase 3 PEDFIC 1 Study

W. Hardikar, L. Kjems, E. Lainka, 2021 .

Hepatic Dry Copper Weight in Pediatric Autoimmune Liver Disease

M. Deheragoda, A. Dhawan, N. Hadžić, 2022, Journal of pediatric gastroenterology and nutrition.

Regional Elevation of Liver T1 in Fontan-Associated Liver Disease

E. Tham, J. Pagano, C. Escudero, 2023, CJC Pediatric and Congenital Heart Disease.